Allied Market Research recently published a report, titled, “Biosurgery Market by Product Type (Anti Adhesive Agents, Bone Graft Substitutes, Hemostatic And Surgical Sealant, Mesh), by Application (Cardiovascular And Thoracic Surgery, Neuro And Spine Surgery, Orthopedic Surgery, General Surgery), by Source (Biologics Products, Synthetic Products): Global Opportunity Analysis and Industry Forecast, 2020-2030.” According to the analyst of AMR, the global biosurgery industry generated $11.42 billion in 2020, and is expected to reach $27.32 billion by 2030, witnessing a CAGR of 9.1% from 2021 to 2030.
Download Sample Report for More Insights- https://www.alliedmarketresearch.com/request-sample/1235
Biosurgery Market Overview:
Rise in spending on R&D activities by researchers, private companies, and government organizations, strategies adopted by top players such as new product launches, and surge in prevalence of severe traumatic injuries drive the growth of the global biosurgery market. However, expensive nature of biosurgery products and stringent regulations restrain the market growth. On the other hand, rise in number of surgical procedures and surge in number of sports-related injuries present opportunities in the coming years.
Biosurgery Market Segmentation:
The neuro- and spine surgery segment to maintain its lead position throughout the forecast period
Based on application, the neuro- and spine surgery segment accounted for the highest market share in 2020, accounting for nearly two-fifths of the global biosurgery market, and is projected to maintain its lead position throughout the forecast period. This is attributed to increase in prevalence of the neurological disorder. However, the general surgery segment is projected to manifest the largest CAGR of 10.2% from 2021 to 2030, owing to rise in incidence of surgeries, surge in sedentary lifestyle, and increase in the geriatric population.
The mesh segment to maintain its leadership status during the forecast period
Based on product type, the mesh segment held the highest market share in 2020, contributing to more than one-third of the global biosurgery market, and is projected to maintain its leadership status during the forecast period. This is due to increase in incidence of surgeries such as cardiovascular surgery and general abdominal surgery that raise the demand for anti-adhesive agents. However, the bone graft substitutes segment is estimated to manifest the largest CAGR of 10.5% from 2021 to 2030, owing to rise in demand for bone graft substituent products and increase in number of sports injuries and surgeries.
North America to maintain its dominance in terms of revenue by 2030
Based on region, North America contributed the highest market share in terms of revenue in 2020, accounting for nearly two-fifths of the global biosurgery market, and is expected to maintain its dominance in terms of revenue by 2030. This is due to increase in prevalence of chronic disease, rise in number of surgeries, presence of key players in manufacturing biosurgery products, and surge in development in R&D activities in the healthcare sector. However, Asia-Pacific is projected to portray the fastest CAGR of 10.2% during the forecast period, owing to rise in number of sport-related surgery and injury and increase in demand for biosurgery products.
For Purchas Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/1235
Biosurgery Market: By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Important Questions Being Answered by the Biosurgery Market Report:
What is the Biosurgery market size and growth?
What are the prominent and latest trends impacting the market?
Which is the largest regional market for Biosurgery?
Key market players discussed in the Biosurgery Market report include Aroa Biosurgery Limited, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., and Tissue Regenix Group.
Top Trending Report:-
Companion Diagnostic Market Size, Share & Growth Outlook 2022-2030
Regenerative Medicine Market Size, Share & Growth Outlook 2022-2030
Wearable Patch Market Size, Share & Growth Outlook 2022-2030
Dental Implants and Prosthetics Market Size, Share & Growth Outlook 2022-2030
IVF Devices and Consumables Market Size, Share & Growth Outlook 2022-2030
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest.”
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.